Search - tctmd.com

Displaying 361 - 380 of 453

Sort: Relevancy | Date

Presentation ECHO 2018

Hypertrophic Cardiomyopathy

Presenter: Muhamed Sarić

April 19, 2018

News Industry News

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

April 05, 2018

News Daily News

Drug for Rare Form of Cardiomyopathy Meets Primary Endpoint in Phase III Trial

Todd Neale

March 30, 2018

News Daily News

Genetic Testing for Cardiomyopathy Less Useful for Racial Minorities

Todd Neale

March 06, 2018

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

News Conference News ACC 2018

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Michael O'Riordan

March 01, 2018

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

News Daily News

Impella Heart Pumps Get Expanded Indication for Cardiogenic Shock in Setting of Cardiomyopathy

Todd Neale

February 13, 2018

Presentation TCT 2017

Preliminary Results of Hybrid, Less-Invasive Left Ventricular Reshaping for Ischemic Cardiomyopathy the St. Antonius Hospital Experience

Presenter: Daniel Burkhoff, Samir R. Kapadia, Patrick Klein

November 01, 2017

Presentation TCT 2017

Getting Surgical-like Results With Alcohol Septal Ablation

Presenter: Carey D. Kimmelstiel, Richard Smalling, Paul Sorajja

October 30, 2017

Presentation TCT 2017

Alcohol Septal Ablation - Learning Techniques Through Proctoring

Presenter: Carey D. Kimmelstiel, Richard Smalling, Srihari S. Naidu

October 30, 2017

Presentation TCT 2017

Building an HCM Program - Benchmarks for Centers of Excellence

Presenter: Carey D. Kimmelstiel, Richard Smalling, Sherif F. Nagueh

October 30, 2017

Presentation TCT 2017

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

Presenter: John S. Douglas Jr, Valerian Fernandes, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

High-grade AV Block After ASA

Presenter: John S. Douglas Jr, Valerian Fernandes

October 30, 2017

Presentation TCT 2017

Might Mitraclip Make Ablation Irrelevant?

Presenter: John S. Douglas Jr, Valerian Fernandes, Paul Sorajja

October 30, 2017

Presentation TCT 2017

Evaluation and Management of AS With Obstructive HCM

Presenter: John S. Douglas Jr, Valerian Fernandes, Srihari S. Naidu

October 30, 2017

Presentation TCT 2017

When to Declare Victory

Presenter: John S. Douglas Jr, Valerian Fernandes, Christopher D. Nielsen

October 30, 2017

Presentation TCT 2017

My Worst Complication(s)

Presenter: John S. Douglas Jr, Valerian Fernandes, George S. Hanzel

October 30, 2017

Presentation TCT 2017

My Most Difficult Case(s)

Presenter: John S. Douglas Jr, Valerian Fernandes

October 30, 2017

Presentation TCT 2017

Is Ventricular Arrhythmia After Ablation a Real Phenomenon?

Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel

October 30, 2017

Advertisement

Hypertrophic Cardiomyopathy

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

Drug for Rare Form of Cardiomyopathy Meets Primary Endpoint in Phase III Trial

Genetic Testing for Cardiomyopathy Less Useful for Racial Minorities

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Impella Heart Pumps Get Expanded Indication for Cardiogenic Shock in Setting of Cardiomyopathy

Preliminary Results of Hybrid, Less-Invasive Left Ventricular Reshaping for Ischemic Cardiomyopathy the St. Antonius Hospital Experience

Getting Surgical-like Results With Alcohol Septal Ablation

Alcohol Septal Ablation - Learning Techniques Through Proctoring

Building an HCM Program - Benchmarks for Centers of Excellence

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

High-grade AV Block After ASA

Might Mitraclip Make Ablation Irrelevant?

Evaluation and Management of AS With Obstructive HCM

When to Declare Victory

My Worst Complication(s)

My Most Difficult Case(s)

Is Ventricular Arrhythmia After Ablation a Real Phenomenon?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content